Reaction Details | |||
---|---|---|---|
Report a problem with these data | |||
Target | Mitogen-activated protein kinase 13 | ||
Ligand | BDBM50473626 | ||
Substrate/Competitor | n/a | ||
Meas. Tech. | ChEMBL_124318 (CHEMBL732626) | ||
IC50 | 6.0±n/a nM | ||
Citation | McKenna, JM; Halley, F; Souness, JE; McLay, IM; Pickett, SD; Collis, AJ; Page, K; Ahmed, I An algorithm-directed two-component library synthesized via solid-phase methodology yielding potent and orally bioavailable p38 MAP kinase inhibitors. J Med Chem45:2173-84 (2002) [PubMed] Article | ||
More Info.: | Get all data from this article, Assay Method | ||
Mitogen-activated protein kinase 13 | |||
Name: | Mitogen-activated protein kinase 13 | ||
Synonyms: | MAP kinase 13 | MAP kinase p38 delta | MAPK 13 | MK13_MOUSE | Mapk13 | Mitogen-activated protein kinase 13 | Mitogen-activated protein kinase p38 delta | Serk4 | Stress-activated protein kinase 4 | ||
Type: | PROTEIN | ||
Mol. Mass.: | 42081.17 | ||
Organism: | Mus musculus | ||
Description: | ChEMBL_105000 | ||
Residue: | 366 | ||
Sequence: |
| ||
BDBM50473626 | |||
n/a | |||
Name | BDBM50473626 | ||
Synonyms: | CHEMBL71572 | RPR-239938 | ||
Type | Small organic molecule | ||
Emp. Form. | C27H29FN6O4 | ||
Mol. Mass. | 520.5554 | ||
SMILES | CCCNC(=O)[C@@]1(C)CO[C@@H](OC1)c1nc(c([nH]1)-c1ccnc(NCc2ccco2)n1)-c1ccc(F)cc1 |wU:10.13,6.6,wD:6.5,(23.17,-14.45,;22.4,-13.11,;23.18,-11.78,;22.42,-10.43,;20.88,-10.43,;20.1,-11.76,;20.11,-9.1,;20.88,-7.77,;19.35,-7.77,;17.82,-7.77,;17.04,-9.1,;17.82,-10.43,;19.33,-10.43,;15.5,-9.1,;14.59,-10.34,;13.12,-9.86,;13.13,-8.3,;14.61,-7.84,;11.8,-7.53,;11.8,-5.99,;10.45,-5.22,;9.12,-5.99,;9.12,-7.53,;7.79,-8.3,;6.46,-7.53,;5.12,-8.3,;3.72,-7.69,;2.69,-8.83,;3.46,-10.17,;4.96,-9.85,;10.45,-8.3,;11.88,-10.76,;12.04,-12.28,;10.8,-13.19,;9.38,-12.56,;8.04,-13.32,;9.22,-11.01,;10.48,-10.12,)| | ||
Structure |